Comparison of Oral Thiazides vs Intravenous Thiazides vs Tolvaptan in Combination With Loop Diuretics for Diuretic Resistant Decompensated Heart Failure

Trial Profile

Comparison of Oral Thiazides vs Intravenous Thiazides vs Tolvaptan in Combination With Loop Diuretics for Diuretic Resistant Decompensated Heart Failure

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2018

At a glance

  • Drugs Chlorothiazide (Primary) ; Tolvaptan (Primary) ; Metolazone
  • Indications Hypervolaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jan 2018 Planned End Date changed from 1 Mar 2019 to 1 May 2019.
    • 23 Jan 2018 Planned primary completion date changed from 1 Mar 2018 to 1 May 2018.
    • 31 Oct 2016 Planned End Date changed from 1 Sep 2018 to 1 Mar 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top